Skip to main content
Skip to section navigation
Skip to footer
Medical Professionals
Information for Healthcare Providers
Clinical Studies
Expanded Access
Educational Grants
Request Information
Press Releases
Suppliers
Atara Biotherapeutics
Our Company
About Us
Responsibility
Technology
Technology
Manufacturing
CAR T
Pipeline
Atara Pipeline
Tab-cel
®
ATA3219
ATA3431
Patients & Families
Our Mission
ATA3219 Trial (NHL)
ATA3219 Trial (SLE/LN)
Stories of Strength
About EBV
PTLD
Clinical Studies
Expanded Access
Investors & Media
Investors & Media
News & Events
Financial Results
ATRA Stock
Analyst Coverage
SEC Filings
Governance
Careers
Careers Home
Career Areas
Job Search
Contact
Medical Professionals
Press Releases
Suppliers
LinkedIn
Twitter
News
Careers
Investors & Media
Investors & Media
Investors & Media
News & Events
Overview
Press Releases
Events
Presentations
Email Alerts
Investor & Media Contacts
Financial Results
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
ATRA Stock
Overview
Charts
Historical Data
FAQ
Classification Info
Analyst Coverage
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Contact the Board
Investor Relations
News & Events
Press Releases
Year
All Years
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
Category
All Releases
Financial Releases
Search terms
Submit
Dec 17, 2013 7:00 am EST
Atara Biotherapeutics Secures $38.5 Million Series B Financing
Previous Page
arrow_back
Page
1
…
…
Page
28
Page
29
Page
30
Page
31
Page
32
Page
33
Page
34
Page
35
Page
36
Page
37
rss_feed
News RSS
Email Alerts
Contacts
RSS News Feed